UncoverDC By Michelle Edwards -April 12, 2022
A critical Danish study published last week in The Lancet examined the possible non-specific effects (NSEs) of the novel COVID-19 vaccines. The study suggests that traditional adenovirus-based vaccines such as Johnson & Johnson and AstraZeneca may be safer for overall mortality—including COVID-19 deaths, accidental deaths and cardiovascular deaths—than the experimental mRNA-based “vaccines” manufactured by Pfizer and Moderna. The preprint, titled “Randomised Clinical Trials of COVID-19 Vaccines: Do Adenovirus-Vector Vaccines Have Beneficial Non-Specific Effects?,” notes:
“Given the public health importance, we used the final study reports currently available from the clinical testing to examine the impact of mRNA and adenovirus-vector vaccines on overall mortality, including COVID-19-related mortality, accidents, cardiovascular deaths and other non-COVID-19 mortality.”
After reviewing the randomized clinical trials (RCTs) for the four vaccine candidates, the April 5, 2022 preprint reports that for overall mortality, with 74,193 participants and 61 deaths (mRNA:31; placebo:30), the relative risk (RR) for the Pfizer and Moderna mRNA “vaccines” compared with the placebo was 1.03. Comparatively, in the adenovirus-based vaccines there were 122,164 participants and 46 deaths (vaccine:16; controls:30). The RR for the adenovirus-based vaccines (Johnson & Johnson and AstraZeneca) versus the placebo/control vaccine was 0.37. The study notes that the adenovirus-based vaccines also demonstrated protection against COVID-19 deaths (RR=0.11), non-accident and non-COVID-19 deaths (RR=0.38). Nonetheless, as illustrated in the table below, the two types of vaccines were significantly different with respect to an impact on overall mortality.
The study explains that there now exists “ample evidence that vaccines can have broad heterologous effects on the immune system.” Furthermore, “these effects can lead to additional protection or increasing susceptibility to unrelated infections or even non-infectious immune-mediated diseases.” Expanding on this understanding further, the researchers explain that the current system for testing vaccines does not incorporate potential unexpected outcomes, adding:
“Therefore, as it has now been established in numerous studies, vaccines may have completely unexpected effects on overall mortality, different from what could be anticipated based on the protection against the vaccine-targeted disease.”
More:
https://uncoverdc.com/2022/04/12/study-higher-overall-mortality-with-mrna-jabs-vs-adenovirus-vaccines/
